Success rates of trabeculectomy with adjunctive mitomycin C are lower in patients of Hispanic descent than European descent.
A three-hour hearing before the Senate Finance Committee revealed that the health secretary was on uncertain ground even with some Republicans who voted to confirm him. By Sheryl Gay Stolberg and ...
Introduction: Fanconi anemia (FA) is a rare autosomal recessive disease characterized by chromosomal instability and increased predisposition to malignancy. The diagnosis of FA requires clinical ...
Panelists discuss how UGN-102, a reverse thermal hydrogel formulation of mitomycin, offers an FDA-approved ablative treatment option for patients with intermediate-risk non-muscle invasive bladder ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. FANCM is crucial in genome maintenance, ...
This episode explores the treatment of patients with intermediate-risk non-muscle-invasive bladder cancer (IR NMIBC), an important topic in urology today. Expert in the field, Marco Moschini, delves ...
A phase 3 trial showed neoadjuvant mitomycin C before TURBT in NMIBC patients was safe. While 12-month recurrence-free survival was similar to standard care, an 18-month trend suggested a possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback